rs3752087
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002747.4(MAPK4):c.112G>A(p.Val38Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.388 in 1,613,580 control chromosomes in the GnomAD database, including 124,988 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as drug response (no stars).
Frequency
Consequence
NM_002747.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.327 AC: 49673AN: 151936Hom.: 9139 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.366 AC: 91131AN: 249292 AF XY: 0.377 show subpopulations
GnomAD4 exome AF: 0.394 AC: 575847AN: 1461528Hom.: 115848 Cov.: 63 AF XY: 0.396 AC XY: 287819AN XY: 727068 show subpopulations
GnomAD4 genome AF: 0.327 AC: 49671AN: 152052Hom.: 9140 Cov.: 32 AF XY: 0.330 AC XY: 24509AN XY: 74318 show subpopulations
ClinVar
Submissions by phenotype
Thalidomide response Other:1
this variant was associated with excellent response to thalidomide (achieving transfusion independence) excellent responsive
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at